6. Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner
JA. Meta-analysis of the prognostic significance of perinodal
spread in head and neck squamous cell carcinomas (HNSCC)
patients. European
journal
of
cancer.
Aug
2006;42(12):1863-1868.
7. Prabhu RS, Hanasoge S, Magliocca KR, et al. Extent of pathologic
extracapsular extension and outcomes in patients with nonoropha-
ryngeal head and neck cancer treated with initial surgical resection.
Cancer. May 15 2014;120(10):1499-1506.
8. Prabhu RS, Magliocca KR, Hanasoge S, et al. Accuracy of com-
puted tomography for predicting pathologic nodal extracapsular
extension in patients with head-and-neck cancer undergoing initial
surgical resection. International journal of radiation oncology,
biology, physics. Jan 1 2014;88(1):122-129.
9. Piccirillo JF. Inclusion of comorbidity in a staging system for head
and neck cancer. Oncology (Williston Park). Sep 1995;9(9):831-
836; discussion 841, 845-838.
10. Couch ME, Dittus K, Toth MJ, et al. Cancer cachexia update in
head and neck cancer: Pathophysiology and treatment. Head &
neck. Jul 2015;37(7):1057-1072.
11. Lazure KE, Lydiatt WM, Denman D, Burke WJ. Association
between depression and survival or disease recurrence in patients
with head and neck cancer enrolled in a depression prevention trial.
Head & neck. 2009;31(7):888-892.
12. Kattan MW, Hess KR, Amin MB, et al. American Joint Committee
on Cancer acceptance criteria for inclusion of risk models for indi-
vidualized prognosis in the practice of precision medicine. CA: a
cancer journal for clinicians. Jan 19 2016.
12
<!-- PageBreak -->
<!-- PageBreak -->